This inventor holds 1 USPTO granted patent. Top assignee: Yissum Research Development Company of the Hebrew University of Jerusalem Ltd.. Active years: 2001.
Company Filing History:
Years Active: 2001
Title: Meir Blaler: Innovator in Neurological Treatments
Introduction
Meir Blaler is a notable inventor based in Jerusalem, Israel. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of neurological and psychotic disorders. His innovative work has led to the development of a unique active derivative of valproic acid.
Latest Patents
Meir Blaler holds a patent for an active derivative of valproic acid aimed at treating neurological and psychotic disorders. The patent describes pharmaceutical compositions and methods for preparing these compositions, which include an effective amount of 2-hydroxylpropyl valpromide (HP-VPD) as the active ingredient. This invention is particularly relevant for treating pain and migraine, showcasing its potential impact on patient care.
Career Highlights
Throughout his career, Meir Blaler has been associated with Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. His work has focused on advancing pharmaceutical solutions that address complex neurological conditions. With a patent portfolio that includes 1 patent, he continues to contribute to the scientific community.
Collaborations
Meir Blaler has collaborated with notable colleagues, including Niv Papo and Boris Yagen. These partnerships have fostered an environment of innovation and research, enhancing the development of effective treatments in the pharmaceutical industry.
Conclusion
Meir Blaler's contributions to the field of pharmaceuticals, particularly through his patent on valproic acid derivatives, highlight his role as an innovator in treating neurological disorders. His work continues to pave the way for advancements in medical treatments.